CME - Pediatric Infectious Diseases: An Evidence-Based Approach

Venue: Hyatt Regency Sarasota

Location: Sarasota, Florida, United States

Event Date/Time: Apr 26, 2010 End Date/Time: Apr 30, 2010
Registration Date: Apr 26, 2010
Early Registration Date: Mar 27, 2010
Report as Spam


SPECIFIC OBJECTIVES FOR THIS COURSE: DAY 1 - PEDIATRIC IMMUNIZATION UPDATE – Epidemiology of specific vaccine-preventable diseases. Newer vaccines. Problem of vaccine refusal. ANTIBIOTIC UPDATE – Trends in antibiotic resistance. Antibiotic usage for common pediatric conditions. Strategies to resist further bacterial resistance, as recommended by the CDC. SERIOUS INFECTIONS OF THE HEAD AND NECK – Differences and similarities in the clinical appearance, diagnosis and treatment of peritonsillar, retropharyngeal and parapharyngeal space infections. Approach to red, swollen eye or cheek. THE CHILD WITH “TOO MANY” INFECTIONS – Evaluation of the child with frequent infections. Presentation of the most common causes of recurrent infections, when to consider immune deficiency states, management issues for physician providing pediatric healthcare. DAY 2 - THE AGE OF MRSA – Emergence and development of drug resistance that led to MRSA. Prevalence differences and clinical diagnosis and treatment of community and hospital associated MRSA. Importance of accurate and timely diagnosis when confronted with the possibility of MRSA. Management according to clinical scenario and severity. Preventive measures to reduce the risk and incidence of MRSA. CASES FROM THE FILES OF A PEDIATRIC ID CONSULTANT – Instructive pediatric infectious diseases cases and approaches to a variety of interesting clinical challenges. Non-infectious conditions may masquerade as infectious diseases and history is the key to most diagnoses. FEVER AND RASH – Distinctive clinical illnesses with fever and rash. Approach to clinical and laboratory diagnosis. KAWASAKI DISEASE – Clinical/laboratory manifestations. Evaluate and manage patients according to AAP/AHA guidelines. Potential for coronary complications. DAY 3 - ACUTE OTITIS MEDIA – Trends in resistance in pediatric pathogens. Recommendations in AAP/AAFP guidelines. Empiric antibiotic therapy. TICK-BORNE INFECTIONS: HOT SPOTS AND BULLSEYES – Epidemiology of tick-borne infections. Clinical/laboratory manifestations. Therapy, incorporating recent IDSA guidelines. FEVER IN INFANTS – Common bacterial pathogens associated with fever in infants < 8 weeks of age as compared to older infants. Current diagnostic evaluation. Treatment options. LOWER RESPIRATORY INFECTIONS – Association of age, seasonal, clinical presentation, and chest x-ray findings with etiology of pediatric pneumonia. Diagnostic approach to infants and children suspected to have pneumonia, treatment options, implications of emerging bacterial resistance. DAY 4 - VIRUS X – Pathophysiology of Epstein-Barr virus infection. Diverse clinical manifestations of EBV infection. Laboratory work-up based on the situation. INFLUENZA – Changes in influenza epidemiology. Recommendations for immunization. Options for antiviral prophylaxis and treatment. URINARY TRACT INFECTIONS – Clinical situations in which urinary tract infections should be considered. Diagnostic methods for urinary tract infection, their reliability and application, and their limitations. Treatment options. Controversies concerning follow-up and prevention strategies. INFECTIOUS DISEASES – Common and emerging infectious diseases. Important symptoms and signs. Plan for management. DAY 5 - PEDIATRIC MENINGITIS – Common presenting features of bacterial and viral meningitis. Pathogens and treatment concerning bacterial meningitis in children. Management priorities and potential complications of bacterial meningitis. Effects of immunization practices on bacterial meningitis. CAT SCRATCH DISEASE – Clinical presentation of cat scratch disease and the general approach to diagnosis. Use and limitations of diagnostic laboratory testing options. Treatment for the various clinical conditions associated with Bartonella henselae infection. LYMPHADENOPATHY – Differentiate serious from reactive adenopathy. Approach patient based on location and tempo of adenopathy. Laboratory aids in diagnosis. CONGENITAL INFECTIONS – Clinical / laboratory evidence of different infections. Role maternal serologic testing. Therapy and long-term management plans.


1000 Boulevard of the Arts
United States

Additional Information

Physician Fees $745.00 Regular Registration (30 days prior to seminar start date) $795.00 Late Registration Non Physician/Resident* Fees $645.00 Regular Registration (30 days prior to seminar start date) $695.00 Late Registration